If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksManolete Partn. Regulatory News (MANO)

Share Price Information for Manolete Partn. (MANO)

Share Price is delayed by 15 minutes
Get Live Data
40.50    -0.50 (-1.22%)
Bid:
39.00
Ask:
42.00
Spread: 3.00 (7.692%)
Market Cap: £17.81m
MANO Live PriceLast checked at - London Stock Exchange

Intraday Manolete Partn. Share Chart

Director/PDMR Shareholding

17 Oct 2024 12:35

RNS Number : 6369I
Manolete Partners PLC
17 October 2024
 

17 October 2024

 

Manolete Partners PLC

("Manolete" or the "Company")

 

Director/PDMR Dealings

 

Manolete Partners Plc (AIM:MANO), the leading quoted UK insolvency litigation financing company has been notified that Steven Cooklin, Chief Executive Officer and PDMR, has today instructed the transfer of a total of 2,500,000 ordinary shares of 0.4p each in the Company ("Ordinary Shares"), into trusts for his sons, as part of his family inheritance planning.

 

The beneficiaries of the trusts are not defined as persons closely associated with Steven Cooklin under the EU Market Abuse Regulations.

 

Following the transfer, Steven Cooklin's resultant interest in Ordinary Shares is 4,342,199, representing 9.92 per cent. of Manolete's issued share capital.

 

 

The information set out below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014.

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Steven Cooklin

 

 

2

Reason for the notification

a)

Position/status

 

PDMR, Chief Executive Officer

 

 

b)

Initial notification /Amendment

 

Initial Notification

 

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

 

Manolete Partners plc

b)

 

LEI

 

213800R2X9V3KWCC4H47

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted  

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary Shares of 0.4 pence each

 

 

ISIN: GB00BYWQCY12

 

b)

 

Nature of the transaction

 

Transfer of Ordinary Shares into family trusts

 

 

c)

 

Price(s) and volume(s)

 

 

 Price(s)

Volume(s)

Nil consideration

 

1,250,000

 

Nil consideration

 

1,250,000

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

2,500,000 Ordinary shares

 

Nil consideration

e)

 

Date of the transaction

 

17 October 2024

 

 

f)

 

Place of the transaction

 

Outside a trading venue

 

 

For further information please contact:

 

Manolete Partners

via Instinctif Partners

Steven Cooklin (Chief Executive Officer)

 

 

 

Canaccord (NOMAD and Sole Broker)

+44 (0)20 7523 8000

Emma Gabriel

 

Instinctif Partners

+44 (0)20 7457 2020

Hannah Scott

Tim Linacre

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFFIFFWELSEDS
Date   Source Headline
30th Jun 20265:23 pmRNSDirectors Dealing and TVR
26th Jun 20267:00 amRNS-RManolete ranked in Band 1 by Chambers for 6th year
26th Jun 20267:00 amRNSPosting of Annual Report and Notice of AGM
25th Jun 20267:00 amRNSFull Year Results
19th Jun 20267:00 amRNSNotice of FY26 Results and Investor Presentation
1st Jun 20267:00 amRNSBlock Listing Six Monthly Return
20th May 202612:00 pmRNSDirectorate Change
28th Apr 20263:19 pmRNSHolding(s) in Company
24th Apr 20267:00 amRNSFull Year Trading Update
31st Mar 20267:00 amRNSDirectorate Changes
22nd Dec 20257:00 amRNSGrant of Share Options
22nd Dec 20257:00 amRNSGrant of Share Options
17th Dec 20253:13 pmRNSHolding(s) in Company
1st Dec 20257:00 amRNSBlock Listing Six Monthly Return
25th Nov 20257:00 amRNSDirector/PDMR Shareholding
21st Nov 20254:10 pmRNSHolding(s) in Company
19th Nov 20257:00 amRNSHalf-year results
4th Nov 20257:00 amRNSNotice of Interim Results
16th Sep 20252:41 pmRNSResult of AGM
16th Sep 20257:00 amRNSAGM Update
22nd Aug 20257:00 amRNSDirectorate Change
20th Aug 202512:11 pmRNSPosting of Annual Report and Notice of AGM
11th Aug 20257:00 amRNSBoard Changes
5th Aug 202510:18 amRNSHolding(s) in Company
5th Aug 202510:17 amRNSHolding(s) in Company
1st Aug 20257:00 amRNSTotal Voting Rights
28th Jul 20258:30 amRNSHolding(s) in Company
21st Jul 20257:00 amRNSTruck Cartel Case Settlement
14th Jul 20257:00 amRNS-RMelloMonday Investor Webinar
9th Jul 20251:45 pmRNSHolding(s) in Company
26th Jun 20257:00 amRNSFull Year Results
25th Jun 20257:00 amRNS-RManolete ranked in Band 1 by Chambers
19th Jun 20252:45 pmRNSHolding(s) in Company
19th Jun 20251:54 pmRNSNotice of Results
30th May 20257:00 amRNSBlock Listing Six Monthly Return
29th Apr 20257:00 amRNSTrading Update
7th Apr 202512:41 pmRNSDirectorate Change
28th Mar 20257:00 amRNSNew Revolving Credit Facility with HSBC Bank
4th Feb 20257:00 amRNSUpdate on Cartel Claims
29th Nov 20247:00 amRNSBlock Listing Six Monthly Return
19th Nov 20247:00 amRNSHalf-year Report
24th Oct 20241:49 pmRNSNotice of Results
17th Oct 202412:35 pmRNSDirector/PDMR Shareholding
30th Sep 202411:49 amRNSResult of AGM
20th Sep 20247:00 amRNSGrant of Share Options
6th Sep 20241:41 pmRNSPosting of Annual Report and Notice of AGM
3rd Sep 20247:00 amRNSAudited results for the year ended 31 March 2024
29th Aug 20247:00 amRNSRetail Investor Presentation
25th Jul 20245:09 pmRNSPCA Shareholding
27th Jun 20247:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.